Amit Singal, MD MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    06/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Eisai
    Date added:
    Date updated:
    06/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Exelixis
    Date added:
    Date updated:
    06/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genentech
    Date added:
    Date updated:
    06/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Roche
    Date added:
    Date updated:
    06/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Glycotest
    Date added:
    Date updated:
    06/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Exact Sciences
    Date added:
    Date updated:
    06/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    GRAIL
    Date added:
    Date updated:
    06/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Wako Diagnostics
    Date added:
    Date updated:
    06/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AstraZeneca
    Date added:
    12/06/2021
    Date updated:
    06/10/2024
Return to 120 Hepatocellular Carcinoma Conference (HCC) (040122)